Susan Night

Sr. Vice President, Strategy & Growth

Translational Drug Development (TD2)

Susan Night is responsible for creating TD2’s strategic vision and working across the company to execute the subsequent initiatives that sustain and grow the organization.
Susan has 25 years in the healthcare and clinical research industries spanning strategic planning, regulation, policy, and law. Susan served as a Senior Health Policy and Ethics Fellow for the Eliminating Disparities in Clinical Trials (EDICT) Project at Baylor College of Medicine, focused on developing national policy solutions to disparities in participation in clinical trials. She is the co author of several key books: Risk & Reward, A “How-To” Guide to Choosing an MSO (MGMA), and The Texas Medical Jurisprudence Examination: A Self-Study Guide. Before joining TD2, Susan led research site operations in the 60 community oncology practices for McKesson Specialty Health, US Oncology Research.
She received her B.S. from the University of Oklahoma and her JD and Masters in Health Law degree from St. Mary’s University School of Law and University of Houston Law Center.